Dyne Therapeutics (DYN) Other Working Capital Changes (2019 - 2026)

Dyne Therapeutics (DYN) has reported Other Working Capital Changes for 8 consecutive years, with -$9.5 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Other Working Capital Changes fell 530.31% year-over-year to -$9.5 million; the TTM figure through Jun 2026 stood at $25.2 million (up 4613.86% YoY), while the FY2025 annual figure was -$986000.0, down 109.36% from the prior year.
• Other Working Capital Changes slipped to -$9.5 million in Q2 2026 per DYN's latest filing, from $32.8 million in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $32.8 million in Q1 2026 and bottomed at -$14.8 million in Q2 2022.
• Historically, Other Working Capital Changes has averaged $1.9 million across 5 years, with a median of $1.8 million in 2023.
• Annual changes were most pronounced in 2022 — Other Working Capital Changes surged 4775.83% — and 2023, when it sank 707.45%.
• Dyne Therapeutics' Other Working Capital Changes stood at -$510000.0 in 2022, then tumbled by 707.45% to -$4.1 million in 2023, then surged by 199.42% to $4.1 million in 2024, then slumped by 46.31% to $2.2 million in 2025, then slumped by 531.48% to -$9.5 million in 2026.
• Business Quant data shows DYN's Other Working Capital Changes at -$9.5 million in Q2 2026, $32.8 million in Q1 2026, and $2.2 million in Q4 2025.